[
    {
        "content": "* LivaNova Plc - \u200dQ3 2017 diluted earnings per share were $0.57\u200b",
        "date": "11022017",
        "name": "LivaNova PLC",
        "news_type": "topStory",
        "symbol": "LIVN",
        "title": "BRIEF-LivaNova Plc reports \u200dQ3 diluted earnings per share were $0.57\u200b "
    },
    {
        "content": "* Livanova receives FDA approvals for SenTiva device and next-generation VNS therapy programming system for treatment of epilepsy",
        "date": "10092017",
        "name": "LivaNova PLC",
        "news_type": "topStory",
        "symbol": "LIVN",
        "title": "BRIEF-Livanova receives FDA approval for Vagus Nerve Stimulation Therapy system\u200b "
    },
    {
        "content": "* Livanova and Microport announce the approval of Rega pacemakers by the China Food and Drug Administration",
        "date": "09272017",
        "name": "LivaNova PLC",
        "news_type": "topStory",
        "symbol": "LIVN",
        "title": "BRIEF-Livanova and Microport announce approval of Rega pacemakers by China FDA "
    },
    {
        "content": "* Says \u200dreceived FDA 510(k) clearance for U.S. Market launch of its Optiflow Arterial Cannulae Family\u200b Source text for Eikon: Further company coverage:",
        "date": "09252017",
        "name": "LivaNova PLC",
        "news_type": "topStory",
        "symbol": "LIVN",
        "title": "BRIEF-Livanova announces U.S. Launch of Optiflow Arterial Cannulae Family "
    },
    {
        "content": "* LivaNova Plc - \u200dExpects to achieve revenue growth in mid-single-digits in near term and high-single-digits in long term\u200b",
        "date": "09142017",
        "name": "LivaNova PLC",
        "news_type": "topStory",
        "symbol": "LIVN",
        "title": "BRIEF-LivaNova \u200dexpects to achieve revenue growth in mid-single-digits in near term and high-single-digits in long term\u200b "
    },
    {
        "content": "* Q2 earnings per share view $0.82  revenue view $315.6 million -- Thomson Reuters I/B/E/S",
        "date": "08092017",
        "name": "LivaNova PLC",
        "news_type": "topStory",
        "symbol": "LIVN",
        "title": "BRIEF-Livanova \u200dQ2 adjusted EPS $1.01\u200b "
    },
    {
        "content": "* VNS Therapy receives FDA approval for expanded mri labeling",
        "date": "06212017",
        "name": "LivaNova PLC",
        "news_type": "topStory",
        "symbol": "LIVN",
        "title": "BRIEF-VNS Therapy receives FDA approval for expanded MRI Labeling "
    },
    {
        "content": "* Livanova Plc -  Thad Huston will join company as its new chief financial officer effective May 20  2017",
        "date": "05162017",
        "name": "LivaNova PLC",
        "news_type": "topStory",
        "symbol": "LIVN",
        "title": "BRIEF-Livanova announces Thad Huston as chief financial officer "
    },
    {
        "content": "* Says acquisition will be dilutive to earnings for several years",
        "date": "05022017",
        "name": "LivaNova PLC",
        "news_type": "topStory",
        "symbol": "LIVN",
        "title": "BRIEF-LivaNova acquires Caisson Interventional  LLC "
    },
    {
        "content": "* Livanova to unveil new data further demonstrating the perceval sutureless valve is a safe and effective aortic valve replacement for patients",
        "date": "04282017",
        "name": "LivaNova PLC",
        "news_type": "topStory",
        "symbol": "LIVN",
        "title": "BRIEF-Livanova to unveil new data demonstrating perceval sutureless valve is safe  effective aortic valve replacement "
    },
    {
        "content": "* Expects worldwide net sales for full-year 2017 to grow between 1 and 3 percent on a constant-currency basis",
        "date": "03312017",
        "name": "LivaNova PLC",
        "news_type": "topStory",
        "symbol": "LIVN",
        "title": "BRIEF-Livanova Plc reiterates full-year 2017 guidance "
    }
]